Legacy Bridge’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $905K | Sell |
10,909
-7,645
| -41% | -$634K | 0.43% | 77 |
|
|
2025
Q1 | $1.5M | Sell |
18,554
-600
| -3% | -$48.7K | 0.84% | 41 |
|
|
2024
Q4 | $1.73M | Buy |
19,154
+25
| +0.1% | +$2.25K | 0.9% | 32 |
|
|
2024
Q3 | $1.89M | Buy |
19,129
+8
| +0% | +$790 | 1.02% | 27 |
|
|
2024
Q2 | $1.77M | Buy |
19,121
+18,357
| +2,403% | +$1.7M | 1.04% | 28 |
|
|
2024
Q1 | $72.5K | Buy |
764
+467
| +157% | +$44.3K | 0.04% | 179 |
|
|
2023
Q4 | $26.5K | Hold |
297
| – | – | 0.02% | 221 |
|
|
2023
Q3 | $21.7K | Hold |
297
| – | – | 0.02% | 222 |
|
|
2023
Q2 | $24.7K | Hold |
297
| – | – | 0.02% | 220 |
|
|
2023
Q1 | $22.6K | Hold |
297
| – | – | 0.02% | 224 |
|
|
2022
Q4 | $24.7K | Hold |
297
| – | – | 0.02% | 223 |
|
|
2022
Q3 | $24K | Hold |
297
| – | – | 0.02% | 210 |
|
|
2022
Q2 | $22K | Hold |
297
| – | – | 0.02% | 217 |
|
|
2022
Q1 | $27K | Hold |
297
| – | – | 0.02% | 225 |
|
|
2021
Q4 | $33K | Hold |
297
| – | – | 0.02% | 220 |
|
|
2021
Q3 | $37K | Hold |
297
| – | – | 0.02% | 206 |
|
|
2021
Q2 | $40K | Hold |
297
| – | – | 0.02% | 207 |
|
|
2021
Q1 | $40K | Sell |
297
-297
| -50% | -$40K | 0.03% | 203 |
|
|
2020
Q4 | $84K | Hold |
594
| – | – | 0.06% | 170 |
|
|
2020
Q3 | $66K | Hold |
594
| – | – | 0.06% | 169 |
|
|
2020
Q2 | $66K | Buy |
594
+297
| +100% | +$33K | 0.07% | 164 |
|
|
2020
Q1 | $23K | Hold |
297
| – | – | 0.03% | 196 |
|
|
2019
Q4 | $28K | Hold |
297
| – | – | 0.02% | 215 |
|
|
2019
Q3 | $23K | Hold |
297
| – | – | 0.02% | 214 |
|
|
2019
Q2 | $26K | Hold |
297
| – | – | 0.03% | 209 |
|
|
2019
Q1 | $27K | Hold |
297
| – | – | 0.03% | 204 |
|
|
2018
Q4 | $21K | Buy |
+297
| New | +$21K | 0.03% | 186 |
|